07/30/2020
7:44 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2020
3:17 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2020
8:43 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2020
12:23 PM | PDL BioPharma (Filer)
| Form DEF 14A
| |
06/05/2020
3:22 PM | PDL BioPharma (Filer)
| Form PRER14A
| |
05/26/2020
3:34 PM | Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
| Form SC 13D/A
| |
05/21/2020
3:16 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2020
3:08 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2020
8:32 PM | PDL BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2020
6:47 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/21/2020
8:53 PM | Bazaar Alan Lee (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
8:52 PM | Bazaar Alan Lee (Reporting)
PDL BioPharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/07/2020
7:48 AM | PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
7:47 AM | Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
| Form 4/A
| |
04/07/2020
7:47 AM | Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
| Form 4/A
| |
04/07/2020
7:46 AM | Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
| Form 4/A
| |
04/07/2020
7:46 AM | PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
| Form 4/A
| |
04/07/2020
7:46 AM | Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
7:45 AM | Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2020
3:19 PM | PDL BioPharma (Filer)
| Form DEFA14A
| |
03/11/2020
3:16 PM | PDL BioPharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2020
7:33 AM | ENGINE CAPITAL, L.P. (Filed by)
PDL BioPharma (Subject)
| Form SC 13D/A
| |
02/28/2020
7:17 AM | PDL BioPharma (Filer)
| Form DEFA14A
| |
02/28/2020
7:15 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
11:04 AM | PDL BioPharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
01/15/2020
3:34 PM | PDL BioPharma (Filer)
| Form DEFA14A
| |
01/15/2020
11:32 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2020
5:37 PM | Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2020
5:36 PM | PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2020
5:36 PM | Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2020
5:36 PM | Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2020
2:26 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
PDL BioPharma (Subject)
| Form SC 13G
| |
12/23/2019
6:59 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2019
7:33 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2019
7:34 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2019
7:33 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2019
7:04 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
12:21 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
3:14 PM | PDL BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
3:10 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2019
7:56 AM | ENGINE CAPITAL, L.P. (Filed by)
PDL BioPharma (Subject)
| Form SC 13D
| |
10/21/2019
6:05 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2019
3:08 PM | Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
| Form SC 13D/A
| |
09/17/2019
4:08 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2019
8:49 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2019
8:57 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2019
3:42 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2019
3:32 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2019
4:18 PM | Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
| Form SC 13D/A
| |
08/07/2019
3:22 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2019
4:02 PM | MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
11:16 PM | PDL BioPharma (Filer)
| Form EFFECT
| |
06/25/2019
4:24 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2019
8:44 PM | PDL BioPharma (Issuer)
Yanai Shlomo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
8:41 PM | Hernday Natasha (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
8:40 PM | PDL BioPharma (Issuer)
Saks Samuel R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
8:39 PM | PDL BioPharma (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
8:38 PM | GRYSKA DAVID W (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
8:37 PM | O'Farrell Elizabeth G. (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
8:36 PM | PDL BioPharma (Issuer)
Sandman Paul W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
8:34 PM | Hernday Natasha (Reporting)
PDL BioPharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2019
8:32 PM | Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2019
8:06 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
5:16 PM | Evofem Biosciences, Inc. (Issuer)
PDL BioPharma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:02 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
3:07 PM | PDL BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
3:03 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
5:10 AM | PDL BioPharma (Filer)
| Form DEFA14A
| |
04/30/2019
4:14 PM | PDL BioPharma (Filer)
| Form DEFA14A
| |
04/30/2019
4:08 PM | PDL BioPharma (Filer)
| Form DEF 14A
| |
04/18/2019
2:33 PM | Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
| Form SC 13D
| |
04/18/2019
2:29 PM | Evofem Biosciences, Inc. (Issuer)
PDL BioPharma (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2019
4:18 PM | Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
| Form 4/A
| |
04/16/2019
4:17 PM | PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
| Form 4/A
| |
04/16/2019
4:16 PM | GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
| Form 4/A
| |
04/16/2019
4:15 PM | Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
| Form 4/A
| |
04/16/2019
3:10 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2019
4:29 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2019
3:13 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2019
3:33 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2019
4:12 PM | Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
4:12 PM | GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
4:11 PM | Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
4:10 PM | PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2019
6:58 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2019
7:56 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2019
9:55 AM | PDL BioPharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
9:09 AM | PDL BioPharma (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
02/08/2019
7:37 AM | DIMENSIONAL FUND ADVISORS LP (Filed by)
PDL BioPharma (Subject)
| Form SC 13G/A
| |
02/06/2019
2:05 PM | BlackRock Inc. (Filed by)
PDL BioPharma (Subject)
| Form SC 13G/A
| |
01/09/2019
9:26 AM | MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
9:26 AM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2018
5:30 PM | Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
5:30 PM | GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
5:29 PM | PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
5:28 PM | MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2018
7:21 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2018
8:18 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2018
3:03 PM | PDL BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2018
3:08 PM | PDL BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
